Press summary: DK Medtech and Mozarc Medical forge strategic partnership to elevate vascular access care for U.S. dialysis patients with innovative balloon technologies
Suzhou/Minneapolis, June 25, 2025 — DK Medical Technology (Suzhou) Co., Ltd. (DK Medtech), a leading Chinese innovator in interventional balloon technologies, and Mozarc Medical, a global pioneer in kidney health solutions, are forming a strategic collaboration in the U.S. to jointly address clinical challenges kidney disease patients face during dialysis. Kidney disease in the U.S. affects more than 1 in 7 adults.
Yulin Weng, Founder & CEO of DK Medtech: “Partnering with Mozarc is a landmark in DK Medtech’s global journey. Our decade-long dedication to original technologies delivers an answer to specialized vascular balloons.”
Ven Manda, CEO of Mozarc Medical: “Our partnership with DK Medtech could benefit more than 500,000 American dialysis patients. The addition of DKutting™ and DKaptain™ strengthen our Renal Access therapies. Together we are working to improve options for dialysis patients’ AV fistula maintenance.”
Mozarc Medical will serve as the exclusive U.S. distributor for DK Medtech’s DKutting™ PTA Scoring Balloon Dilatation Catheter and DKaptain™ PTA High Pressure Balloon Dilatation Catheter, jointly advancing clinical therapies in dialysis vascular access management.
DKutting™ PTA Scoring Balloon Dilatation Catheter: The balloon catheter combines directional scoring and high-pressure expansion. Its patented nitinol coiled wire scoring design enables precise, controlled dilation of high resistant stenoses in tortuous anastomotic sites, minimizing vessel trauma.
DKaptain™ PTA High Pressure Balloon Dilatation Catheter: Engineered for complex lesions, the catheter can manage burst pressure of up to 26 atm and accommodate vessel diameters from 3.0mm to 12.0mm, covering most full-range clinical needs for vascular access.
About DK Medtech: Founded in 2015 and headquartered in Suzhou, China, DK Medical Technology (Suzhou) Co., Ltd. (DK Medtech) is committed to improving patient lives through innovative coronary, peripheral, neurovascular, and dialysis interventions, with a focus on interventional balloon technologies (e.g., scoring, drug-coated, and high-pressure balloons).
Kidney Disease Statistics for the United States, National Institute for Health, 2024
Kidney Disease Statistics for the United States, National Institute for Health, 2024
About Mozarc Medical: Mozarc Medical, a DaVita and Medtronic company headquartered in Minneapolis, MN, U.S., is committed to bring patient-centric innovation to the field of dialysis, focusing on transformative kidney health therapies, including dialysis access, and pediatric care devices.
